Supreme Pharmaceuticals Announces Debt Settlement for Shares

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/15 -- Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK: SPRWF)(CSE: SL) advises that it has settled outstanding debts by the issuance of 500,000 shares at a deemed price of $0.3375 per share. These shares shall be subject to a 4 month trading restriction.



Contacts:
Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 30.01.2015 - 21:02 Uhr
Sprache: Deutsch
News-ID 368203
Anzahl Zeichen: 0

contact information:
Town:

VANCOUVER, BRITISH COLUMBIA

Kategorie:

Healthcare

Diese Pressemitteilung wurde bisher 211 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Supreme Pharmaceuticals Announces Debt Settlement for Shares"
steht unter der journalistisch-redaktionellen Verantwortung von

Supreme Pharmaceuticals Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Supreme Receives Sales Approval ...

TORONTO, ONTARIO -- (Marketwired) -- 06/28/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (TSX VENTURE: FIRE) is pleased to announce that its wholly-owned operating subsidiary, 7ACRES, has been granted its permi ...

Supreme Provides License Update ...

TORONTO, ONTARIO -- (Marketwired) -- 06/19/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (TSX VENTURE: FIRE) is pleased to announce that the Company's wholly-owned subsidiary, 8528934 Canada Ltd. d/b/a 7 Ac ...

Supreme Announces Listing of Common Shares on the TSX.V under the symbol "F ...

TORONTO, ONTARIO -- (Marketwired) -- 06/01/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (CSE: SL)(CSE: SL.CN)(CNSX: SL)(OTC PINK: SPRWF) is pleased to announce that it has received final approval from the TSX ...

Alle Meldungen von Supreme Pharmaceuticals Inc.